Press release
Stocks FNGR AMFN GMGMF NIVF in the News Plus More Inside
Dallas TX - Sept. 30, 2026 - Fusion-energy, powered infrastructure, manufactoring and exploration headline the latest developments from NIVF, AMFN, FNGR, GMGMF, AMLM and RETO.American Fusion Inc. (OTCQB: AMFN) released a technical analysis by Chief Technology Officer Dr. John E. Brandenburg explaining Texatron Trademark 's proposed approach to compressing, heating and stabilizing plasma. The platform is being developed to use deuterium and helium-3, with the goal of recovering electricity directly from fusion energy without steam turbines. Further experiments will evaluate plasma conditions and energy recovery; fusion ignition, net energy gain and direct electricity conversion remain undemonstrated objectives.
FingerMotion, Inc. (NASDAQ: FNGR) entered into a definitive agreement to acquire 100% of Newbit Technology Inc. for US$2.3 million in cash, excluding GST and subject to customary adjustments. Newbit holds permits, land-use rights, pipeline and metering infrastructure, regulatory registration and related rights for FingerMotion's previously disclosed 9.9 MW behind-the-meter powered site in Alberta, known as Brooks Campus #1. If completed, the acquisition would consolidate ownership of those site assets and rights.
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) closed an approximately US$10 million private placement, issuing 6,465,336 ordinary shares at CA$2.15 each. The financing supports graphene production, battery-cell capacity and commercialization as GMG advances its Gen 2.0 manufacturing plant, G Registered CELLS battery technology and G FLUID Trademark coolant targeting industrial and AI-data-center cooling.
NewGenIvf Group Limited (NASDAQ: NIVF) announced pricing of a public offering expected to generate approximately $1.25 million in gross proceeds, before fees and expenses. The reasonable best-efforts offering comes as the diversified company pursues activities spanning reproductive health, real estate development and digital asset management.
American Lithium Minerals, Inc. (OTC: AMLM) completed its PCAOB audit and is targeting a Q4 2026 OTCQB uplisting. Its 11 active global project interests span gold, silver, copper, lithium and rare earth elements, highlighting a diversified exploration portfolio beyond its namesake commodity.
ReTo Eco-Solutions, Inc. (NASDAQ: RETO) approved a 20-for-1 combination of its Class A shares, with trading on the adjusted basis scheduled to begin Oct. 2, 2026.
Additional companies on the broader watchlist include SunHydrogen, Inc. (OTCQB: HYSR) PetVivo Holdings (OTCQX: PETV), Freight Technologies (NASDAQ: FRGT), and Clifton Mining (OTC: CFTN).
About the Companies
The featured companies operate across reproductive health and diversified investments, fusion-energy development, technology and powered infrastructure, advanced materials, mineral exploration and environmental equipment.
About The Street Reports
The Street Reports (TSR) is a financial media awareness platform focused on emerging-growth, small-cap, micro-cap and nano-cap companies. The Street Reports publishes and distributes market-focused content across financial news, media and digital channels, providing companies with expanded visibility and exposure to a broad audience of readers and market participants.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stocks-fngr-amfn-gmgmf-nivf-in-the-news-plus-more-inside]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stocks FNGR AMFN GMGMF NIVF in the News Plus More Inside here
News-ID: 4649117 • Views: …
More Releases from ABNewswire
Hepatitis B Virus Infection Clinical Trial Drug Development Pipeline Expands wit …
The Hepatitis B Virus Infection Clinical Trials analysis report delivers important insights into ongoing research of 80+ pipeline Hepatitis B Virus Infection Drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
(Albany, US) September 30, 2026 - DelveInsight's "Hepatitis B Virus Infection Pipeline Insight 2026" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline…
Toronto Jeweller Celebrates Over 30 Years of Creating Custom Engagement Rings
Budget Diamonds Online, a family-owned Toronto jeweller, celebrates more than 30 years of jewellery experience creating custom engagement rings with natural and lab-grown diamonds.
TORONTO, ON - September 30, 2026 - For more than three decades, Budget Diamonds Online has been helping couples celebrate life's biggest milestones with custom-made engagement rings designed to reflect their individual style and story. Located in Toronto's Diamond District, the family-owned jeweller has built its reputation…
Hepatic Tumor Clinical Trial Drug Development Pipeline Expands with Contribution …
The Hepatic Tumor Clinical Trials analysis report delivers important insights into ongoing research on 75+ pipeline Hepatic Tumor Drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
(Albany, US) September 30, 2026 - DelveInsight's "Hepatic Tumor Pipeline Insight 2026" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Hepatic Tumor pipeline landscape. It covers the Hepatic Tumor pipeline drug profiles, including clinical and nonclinical stage products. It also…
Manhattan Legal Separation Attorney Ryan Besinque Explains Separation Mediation …
NEW YORK, NY - September 30, 2026 - Couples considering separation in New York have options beyond contested court proceedings, including a voluntary, out-of-court process that allows spouses to negotiate the terms of a legally binding separation agreement. Manhattan legal separation attorney Ryan Besinque of The Law Office of Ryan Besinque (https://www.besinquelaw.com/what-is-separation-mediation/) is providing guidance on how separation mediation works, what issues it resolves, and its legal effects under New…
More Releases for GMG
High-Impact Stocks DRK, VIVS, AEMD, GMG in the News
Sept. 17, 2026 - Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), VivoSim Labs, Inc. (NASDAQ: VIVS) and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) following developments across AI infrastructure, predictive toxicology and graphene manufacturing.
DarkHorse Technologies, Inc. (NASDAQ: DRK) Begins Trading Today! Focusing on Digital infrastructure, scalable power, and data center assets for high-performance computing and AI workloads, operates power capacity across locations in Tennessee and Kentucky. Formerly Sphere…
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) Battery Breakthrough, Asia Exp …
September 14, 2026 Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is adding new potential catalysts to its 2026 growth story, led by encouraging results from its next-generation G Registered CELLS graphene battery technology and expansion of its commercial sales presence across Asia-Pacific.
GMG reported that its 1 Ah G Registered CELLS completed 489 cycles with no performance reduction as of September 4, 2026, despite being charged and discharged in just…
U.S./Canada Stocks GMG, KEEL, OMG, FF Offer Dual-Market Opportunity
Aug. 20, 2026 Investors looking across both U.S. and Canadian markets are watching a group of dual-listed companies spanning graphene technology, infrastructure, gold mining, critical materials and energy storage. Graphene Manufacturing Group, Keel Infrastructure, Omai Gold Mines and First Mining Gold each have recently reported developments that could keep the companies on investor radar.
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is accelerating commercialization through an exclusive global MOU with…
Which Companies Lead the Generalized Myasthenia Gravis Treatment (gMG) Market in …
DataM Intelligence has published its latest research report, "Generalized Myasthenia Gravis Treatment Market Size 2026." The report provides comprehensive analysis of market dynamics, including regional growth patterns, segment-wise performance, CAGR forecasts, competitive positioning, and revenue trends across key industry participants. It also examines the major factors influencing market expansion, emerging business opportunities, and strategic developments. Designed to support informed business planning, the study delivers a clear assessment of market value,…
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Nearly USD 3.2 b …
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Phase with Breakthrough Biologic Therapies
Snippet / Teaser:
The global Generalized Myasthenia Gravis (gMG) market is witnessing accelerated growth as awareness improves, advanced biologic therapies gain adoption, and rare-disease healthcare infrastructure expands worldwide. With rising diagnosis rates and strong therapy pipelines, gMG is emerging as a high-value segment in autoimmune and neuromuscular disorder treatment.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72089
1. Keyword Definition…
Generalized Myasthenia Gravis (gMG) Market is expected to reach $9.8 billion by …
Generalized myasthenia gravis (gMG) is a rare, chronic autoimmune neuromuscular disorder characterized by muscle weakness, fatigue, and impaired communication between nerves and muscles. It is caused by autoantibodies-primarily against acetylcholine receptors (AChR) or muscle-specific kinase (MuSK)-that disrupt neuromuscular transmission. gMG significantly impacts patients' quality of life, often leading to difficulties in mobility, vision, swallowing, and breathing.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72089
Historically, treatment revolved around acetylcholinesterase inhibitors…
